tm logo
OXC-BETA
REGISTERED

on 17 Jun 2019

Last Applicant/ Owned by

AVIVAGEN INC.

100 Sussex DriveOttawa

ONTARIO

CA

K1A0R6

Serial Number

1789313 filed on 29th Jun 2016

Registration Number

TMA1025617 registered on 17th Jun 2019

Registration expiry Date

17th Jun 2029

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

OXC-BETA

Trademark usage description

adjuvants for use with vaccines; animal feed additives and supplements; anti-infectives for veterinary use; anti-inflammatories; dietary, nutritionals Read More

Classification Information


Class [005]
Adjuvants for use with vaccines; Animal feed additives and supplements; Anti-infectives for veterinary use; Anti-inflammatories; Dietary, nutritionals and food supplements for general health and well-being; Nutritional supplements for general health and well-being; Dietary food supplements for general health and well-being; Non-medicated additives for animal feed for use as nutritional supplements; Nutritional supplements for supporting immune function namely for the treatment of immune compromised individuals to protect them from nosocomial infections namely urinary tract infections, surgical site infections, gastroenteritis, meningitis and pneumonia; Nutritional supplements for supporting immune function namely for the treatment of compromised immune function caused by aging, chronic malnutrition, severe burns, Clostridium difficile, Klebsiella, E. coli, Salmonella and chronic diseases namely diabetes; Nutritional supplements for supporting immune function namely for treatment of canine atopic dermatitis, pododermatitis, alopecia as a result of Cushing's Disease and Hypothyroidism, feline immunodeficiency virus, feline leukemia virus, oral rodent ulcers and feline asthma; Nutritional supplements for cats, dogs, horses, livestock for general health and well-being; Pharmaceutical preparations for treatment of infectious diseases, namely respiratory infections, eye infections; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for treating skin disorders and for use in dermatology of animals namely canine atopic dermatitis, acute and chronic otitis externa, hot spots, secondary bacterial infections, pododermatitis, like granulomas, acute and chronic otitis externa; Pharmaceutical preparations and substances for the treatment of viral, respiratory, gastrointestinal, dermatological, and immune system related diseases and disorders namely shingles, pneumonia and pleuritis; Pharmaceutical preparations for the prevention and treatment of bacteria-based diseases or disorders namely Parvovirus, secondary bacterial skin infections, secondary bacterial respiratory infections, imbalance in gut flora; Pharmaceutical preparations for the treatment of immune system related diseases and disorders namely irritable bowel syndrome, inflammatory bowel diseases namely ulcerative colitis and Crohn's disease, psoriasis, eczema, dermatitis, rosacea, acne vulgaris and mastitis; Pharmaceutical preparations for skin care for animals; Pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; Pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; Pharmaceutical preparations for treatment of respiratory diseases, disorders and infections; Pharmaceutical preparations for the treatment of inflammatory disorders and diseases namely inflammatory bowel diseases, inflammatory connective tissue diseases; Pharmaceutical preparations for use in gastroenterology; Pharmaceutical products for the treatment of joint disease namely arthritis and bursitis; Pharmaceutical preparations for the treatment of the respiratory system; Veterinary preparations for treatment of intestinal bacteria; Veterinary pharmaceutical preparations for animals and poultry to give newborn animals and birds a healthy start; Veterinary pharmaceutical preparations for respiratory and reproductive diseases in cattle; Veterinary pharmaceutical preparations for treatment of bacterial infections in dogs; Veterinary pharmaceutical preparations for the treatment of infectious diseases in poultry; Veterinary pharmaceutical preparations for treatment of infectious disease namely, respiratory infections, eye infections, topical infections; Veterinary pharmaceutical preparations for the treatment of infectious diseases namely swine dysentery, bacterial enteritis, bluecomb, pneumonia; Veterinary pharmaceutical preparations for the treatment of swine bacterial infectious diseases; Veterinary pharmaceutical preparations for treatment of intestinal bacteria


Classification kind code

10

Mark Details


Serial Number

1789313

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 03rd Aug 2018
Allowed
Submitted for opposition 42
on 18th Apr 2018
Advertised
Submitted for opposition 26
on 29th Mar 2018
Approved
Submitted for opposition 27
on 06th Feb 2018
Approval Notice Sent
Submitted for opposition 15
on 28th Aug 2017
Correspondence Created
Submitted for opposition 22
on 17th Feb 2017
Search Recorded
Submitted for opposition 20
on 17th Feb 2017
Examiner's First Report
Submitted for opposition 31
on 06th Jul 2016
Formalized
Submitted for opposition 1
on 30th Jun 2016
Created
Submitted for opposition 30
on 29th Jun 2016
Filed